Skip to main content
Premium Trial:

Request an Annual Quote

OraSure Completes $50.6M Buy of DNA Genotek

NEW YORK (GenomeWeb News) – OraSure Technologies today announced it has completed its purchase of DNA Genotek for C$50 million (US$50.6 million) in cash.

DNA Genoteck, based in Ottawa, Ontario, will operate as a wholly owned subsidiary of OraSure. The deal, announced in late July, provides OraSure a complementary portfolio of products for the collection, stabilization, transportation, and storage of high quality nucleic acid samples, which can then be used for diagnostic and research purposes.

It also gives Bethlehem, Pa-based OraSure, whose products include antibody-based assays for infectious diseases, a presence in the molecular diagnostics space.

DNA Genoteck has more than 3,000 customers in more than 100 countries, OraSure said. In 2010, DNA Genotek generated approximately $14 million in revenues.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.